Patents by Inventor Glenn Browning

Glenn Browning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8524252
    Abstract: The present invention relates to a Mycoplasma hyopneumoniae vaccine strain comprising a mutation in at least one of the genes listed or as deposited with the National Measurements Institute (Australia) under accession number NM04/41259, which strain is temperature sensitive and attenuated, a vaccine comprising such strains and methods and uses thereof.
    Type: Grant
    Filed: May 19, 2010
    Date of Patent: September 3, 2013
    Assignees: Bioproperties Pty Ltd., The University of Melbourne
    Inventors: Rima Youil, Youssef Abs El-Osta, Glenn Browning, Phillip Markham
  • Publication number: 20120135040
    Abstract: The present invention relates to a Mycoplasma hyopneumoniae vaccine strain comprising a mutation in at least one of the genes listed or as deposited with the National Measurements Institute (Australia) under accession number NM04/41259, which strain is temperature sensitive and attenuated, a vaccine comprising such strains and methods and uses thereof.
    Type: Application
    Filed: May 19, 2010
    Publication date: May 31, 2012
    Inventors: Rima Youil, Youssef Abs El-Osta, Glenn Browning, Phillip Markham
  • Publication number: 20060257424
    Abstract: An isolated attenuated circovirus having a mutation in viral nucleic acid encoding viral protein 2 (VP2). The attenuated circovirus is particularly suitable for use in conferring immunity in an animal, particularly birds.
    Type: Application
    Filed: June 14, 2002
    Publication date: November 16, 2006
    Inventors: Glenn Browning, Kelly Tivendale, Peter Scott, Hayley Brown, Brendan Crabb, Michelle Peters